Drug Profile
ARR 15849
Alternative Names: ARL 15849; FPL 15849Latest Information Update: 23 Jan 2007
Price :
$50
*
At a glance
- Originator Astra Arcus USA
- Class Anorectics; Peptides
- Mechanism of Action Cholecystokinin A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 23 Jan 2007 Discontinued - Preclinical for Obesity in United Kingdom (unspecified route)
- 08 Oct 2001 No-Development-Reported for Obesity in United Kingdom (Unknown route)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed